Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesRadiology/Diagnostic ImagingVentura County Health Plan DEXA Coverage | OpenPay…
    Ask Trek AI about this page
    CurrentVentura County Health Care PlanPolicy 017

    Medical Policy for DEXA Scan

    Customize your policy alerts

    Sign up for venturacountyhealthcareplan Policy 017 alerts

    Get alerted when Policy 017 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs coverage and repeat-testing criteria for axial DEXA scans used to assess bone density and fracture risk. It applies to providers requesting DEXA testing for VCHCP members, with limited peripheral testing allowed when central testing cannot be performed or accurately interpreted.

    Policy Summary
    PayerVentura County Health Care Plan
    PolicyMedical Policy for DEXA Scan
    Policy CodePolicy 017
    Change TypeRevised
    Effective DateAug 14, 2014
    Last ReviewFeb 12, 2026
    Next Review DateN/A
    Key ActionFor requests outside the listed criteria, submit specific risk factors or other pertinent clinical information for physician review.
    SourceLink
    POLICY UPDATE CHANGES

    On August 10, 2023, the policy added a disclaimer limiting the guideline primarily to axial DEXA scans and specifying when peripheral scans may be considered.

    On August 10, 2023, the policy revised the listed osteoporosis-associated disorders and added a reference to Milliman Care Guidelines for a complete list.

    On February 20, 2025, the policy modified the initial bone density testing criteria and added an appendix listing disorders associated with osteoporosis.

    The February 12, 2026 review recorded no policy updates.

    2.5 mgGlucocorticoid threshold
    >3% / >20%FRAX risk threshold

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    2 years
    Advanced osteopenia interval
    15 yearsNormal to mild osteopenia interval
    5 yearsModerate osteopenia interval
    2 yearsTreated osteoporosis interval

    Bone Density Testing Criteria

    Initial bone density testing

    Initial bone density testing may be approved when ANY one of the following criteria groups is met.

    Initial DEXA eligibility

    • Glucocorticoid exposure: Adult receiving or anticipated to receive glucocorticoid therapy at a dosage-equivalent of 2.5 mg of prednisone daily for 3 months or more.2.5 mg prednisone daily for 3+ months
    • Age-based eligibility: Woman age 65 or older or man age 70 or older, regardless of additional risk factors.Women >=65; men >=70
    • FRAX eligibility: Any age with a 10-year FRAX probability of hip fracture greater than 3% or all fractures greater than 20%.Hip >3% or all fractures >20%

      Use the United States FRAX calculation tool.

    • Postmenopausal woman under 65

      • Postmenopausal risk factors

        • Prior fracture: Previous fracture sustained after age 50.
        • Parental hip fracture: Parental history of hip fracture.
        • Low body weight: Body weight less than 127 pounds (57.6 kg) or BMI less than 21.<127 lb, <57.6 kg, or BMI <21
        • Smoking: Current cigarette smoking.
    • Premenopausal female

      • Chemotherapy-induced ovulatory failure, such as from cyclophosphamide.
      • Estrogen deprivation therapy, such as gonadotropin-releasing hormone agonists for breast cancer.
    • Transgender woman

      • Age 60 or older: Age 60 years or older.>=60 years
      • Baseline examination needed.

    Repeat bone density testing

    Repeat bone density testing may be approved when ANY one of the following criteria is met.

    Repeat DEXA eligibility

    • Treated osteoporosis with persistent FRAX risk: Diagnosed osteoporosis undergoing treatment and the patient has not achieved less than 3% hip-fracture risk or less than 20% all-fracture risk by FRAX estimate.Every 2 years; hip risk >=3% or all-fracture risk >=20%
    • Untreated osteoporosis: Diagnosed osteoporosis not undergoing treatment.Every 2 years
    • Normal to mild osteopenia.T-score >-1.5; every 15 years

    The policy primarily covers axial (central) DEXA of the hips, pelvis, and spine. Peripheral or appendicular DEXA, such as imaging of the radius, wrist, or heel, may be considered only when the member is bed-bound, unable to move or be moved easily, or unable to undergo an axial scan that can be accurately interpreted. When axial testing is feasible and interpretable, it is the approved study.

    Clinical Thresholds and Categories

    Glucocorticoid therapy
    PopulationAdult receiving or anticipated to receive glucocorticoid therapy
    Prednisone-equivalent dose2.5 mg daily
    Minimum duration3 months or more
    FRAX fracture risk
    Hip fracture probability10-year probability greater than 3%
    All-fracture probability10-year probability greater than 20%
    Calculation toolUse the United States FRAX calculation tool

    Request and Documentation Requirements

    Note

    Physician Review for Exceptions

    Requests that do not meet the initial or repeat-testing criteria may be reviewed case by case by a physician reviewer.

    Documentation Required

    Document Supporting Information

    For case-by-case review, the requestor must provide specific risk factors or other information pertinent to the patient’s circumstances so the referral can be considered for approval.

    Documentation Required

    Document FRAX Risk

    For patients qualifying based on FRAX, document the applicable 10-year fracture probabilities and identify that the United States FRAX calculation tool was used.

    Policy Background

    DEXA measures bone mineral density to evaluate osteoporosis, osteopenia, and fracture risk. Coverage decisions for initial or repeat testing consider the member’s age and sex, prior fracture and other osteoporosis risk factors, glucocorticoid exposure, FRAX fracture-risk estimates, and prior bone-density results. Central or axial testing is preferred; peripheral testing is reserved for situations in which an accurate axial study cannot be performed or interpreted.

    Key Terms

    FRAX
    Full nameFracture Risk Assessment Tool
    PurposeEstimates the 10-year probability of hip fracture and all major fractures
    Policy calculationUse the United States calculation tool
    T-score
    Normal to mild osteopeniaT-score greater than -1.5; repeat testing every 15 years
    Moderate osteopeniaT-score -1.5 to -1.99; repeat testing every 5 years
    Advanced osteopeniaT-score -2.00 to -2.49; repeat testing every 2 years

    Covered Bone Density Assessment

    Initial or repeat bone density assessment meeting policy criteria

    Coverage is available for an initial or repeat bone density assessment when at least one policy criterion is met.

    Covered DEXA indication: Initial or repeat bone density assessment meeting one of the policy's qualifying criteria groups.

    Repeat-Testing Intervals

    DEXA frequency limit
    Eligible conditionDiagnosed osteoporosis undergoing treatment
    FRAX conditionThe patient has not achieved less than 3% hip-fracture risk or less than 20% all-fracture risk
    Repeat intervalEvery 2 years
    DEXA frequency limit
    Eligible categoryNormal to mild osteopenia
    T-scoreGreater than -1.5
    Repeat intervalEvery 15 years

    Authorization Review

    Prior Authorization

    Prior authorization for exceptions

    Requests outside the listed DEXA criteria require case-by-case physician review. Include specific risk factors or other pertinent information with the request for the referral to be considered for approval.

    Noncovered Study Type

    Peripheral DEXA is not covered as the standard study when an axial study can be performed and accurately interpreted. Peripheral testing is limited to circumstances such as being bed-bound, being unable to move or be moved easily, or being unable to undergo an accurately interpretable axial scan.

    Policy Summary
    PayerVentura County Health Care Plan
    PolicyMedical Policy for DEXA Scan
    Policy CodePolicy 017
    Change TypeRevised
    Effective DateAug 14, 2014
    Last ReviewFeb 12, 2026
    Next Review DateN/A
    Key ActionFor requests outside the listed criteria, submit specific risk factors or other pertinent clinical information for physician review.
    SourceLink
    On This Page
    Bone Density Testing CriteriaClinical Thresholds and CategoriesRequest and Documentation RequirementsPolicy BackgroundKey TermsCovered Bone Density AssessmentRepeat-Testing IntervalsAuthorization ReviewNoncovered Study Type
    Alcohol consumption:
    Excessive alcohol consumption of 3 or more drinks per day.
    >=3 drinks/day
  1. Osteoporosis-associated disorder: Presence of a disorder associated with osteoporosis, including the conditions listed in the policy or appendix.
  2. Aromatase inhibitor therapy: Current aromatase inhibitor therapy.
  3. Abnormal plain x-ray: Osteopenia or osteoporosis on plain x-ray.
  4. Bone-loss medication: Use of medications associated with bone loss or reduced bone mineralization.
  5. Early menopause: Natural or surgical menopause before age 45.Age <45
  6. Hypogonadism or delayed puberty: Hypogonadism as a child or delayed or untreated puberty before age 45.Before age 45
  7. Moderate osteopenia.T-score -1.5 to -1.99; every 5 years
  8. Advanced osteopenia.T-score -2.00 to -2.49; every 2 years
  9. Low body weight
    Weight thresholdLess than 127 pounds
    Metric equivalentLess than 57.6 kg
    BMI thresholdBMI less than 21
    Normal to mild osteopenia
    CategoryNormal to mild osteopenia
    T-scoreGreater than -1.5
    Repeat-testing intervalEvery 15 years
    Moderate osteopenia
    CategoryModerate osteopenia
    T-score-1.5 to -1.99
    Repeat-testing intervalEvery 5 years
    Advanced osteopenia
    CategoryAdvanced osteopenia
    T-score-2.00 to -2.49
    Repeat-testing intervalEvery 2 years
  10. Hip fracture probability: >3%
  11. Probability of all major fractures: >20%
  12. Use the FRAX calculation tool for the United States.
  13. Denial Risk

    Criteria Not Met

    Requests outside the listed initial or repeat bone-density testing criteria require case-by-case review by a physician reviewer and supporting clinical information.

    Denial Risk

    Inappropriate Peripheral Study

    Peripheral (appendicular) DEXA scans are not routinely covered when an axial (central) study can be performed and accurately interpreted. Request a peripheral study only when the axial study cannot be performed, such as for a bed-bound, debilitated nursing-home resident or a patient unable to move or be moved easily, or when the axial scan cannot be interpreted accurately.

    • Axial skeleton studies include the hips, pelvis, and spine.
    • Peripheral studies include the radius, wrist, and heel.
    • Document the specific circumstance preventing performance or accurate interpretation of the axial study.
    Axial versus peripheral DEXA
    Axial or central DEXAEvaluates the central skeleton, including the hips, pelvis, and spine
    Peripheral or appendicular DEXAEvaluates sites including the radius, wrist, and heel
    Study distinctionAxial DEXA is the approved standard when it can be performed and accurately interpreted; peripheral testing is limited to specified circumstances
    DEXA frequency limit
    Eligible categoryModerate osteopenia
    T-score-1.5 to -1.99
    Repeat intervalEvery 5 years
    DEXA frequency limit
    Eligible categoryAdvanced osteopenia
    T-score-2.00 to -2.49
    Repeat intervalEvery 2 years